Sample Papers

The editorial team have selected this set of papers from the archive of the journal to give a representative sample of the best of our content.

These papers are available free to read and download.

For more information about the journal visit About the JCB, Submission Guidelines, and Subscription Information.

Would you like your institution to subscribe to the JCB? Use the Library suggestion form.


Commentary

Patenting human genes and mutations: A personal perspective
Ananda Mohan Chakrabarty

Building biotechnology by design: Role of biotechnology in development
Patrick Nef

The UK Government's strategic approach to the biotechnology industry
Lord Sainsbury

Policy

Public–private partnerships in trust-based public health social networking: Connecting organizations for regional disease surveillance (CORDS)
Louise S Greshama, Leslie A Pray, Suwit Wibulpolprasert, Beverly Trayner

Building biotechnology in Okinawa
Yali Friedman     

Startup America: What it includes and opportunities for innovators
David B Orange

Commercial Strategy

The relevance and importance of business development and licensing in the biopharmaceutical industry
Roger Davies

What do hospital labs really need to streamline diagnostic testing: Apple vs. Microsoft environment?
Doug Millar, John Melki

Revitalizing portfolio decision-making at Merck Serono S.A.
Vincent Aurentz, Bernhard Kirschbaum and Markus Thunecke

Building biotechnology teams: Personality does matter
Anne S York, Kim A McCarthy and Todd C Darnold

Valuation/Licensing

Practical approaches to early stage life sciences technology valuations
Stephen Mayhew

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
Nigel Borshell and Adrian Dawkes

Valuation of complex license contracts
Ralph Villiger and Boris Bogdan

Finance

R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public
David R Williams and Richard W Pouder

Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry
J Leslie Glick

When should you fire the founder
William Bains

Intellectual Property

Dominating global intellectual property: Overview of patentability in the USA, Europe and Japan
Thomas J Kowalski, Antonio Maschio and Samuel H Megerditchian

Kinik: Raising the stakes for importing products derived from US patented processes practised abroad
Scott B Familant

International

Bioentrepreneurship in Japan: Institutional transformation and the growth of bioventures
Michael J Lynskey

Biotechnology in Cuba: 20 years of scientific, social and economic progress
Ernesto López Mola, Ricardo Silva, Boris Acevedo, José A Buxadó, Angel Aguilera and Luis Herrera

China 10-Point Patent Checklist: Integrating patents into an overall business strategy for a Western manufacturing entity in China
Catherine Sun, Sharon R Barner and Harold C Wegner

From the Classroom

Using Biotechnology, CSI, and Zombies to Promote Science Education in one of America’s Most Challenging Regions
David Eugene Menshew

Commercial Case Study

Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement
Rob Hanes, Damon Borich